Robin L. Goode

The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

Jeremy R. Graff, Ann M. McNulty, Kimberly R. Hanna et al. · Cancer Research · 2005 · 437 citations · Full text

Medicine, Oncology, Pharmacology +15

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity

Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent et al. · Journal of Clinical Investigation · 2007 · 379 citations · Full text

Medicine, Cancer Biology, Oncology +17

Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice

Larry J. Black, Robin L. Goode · Life Sciences · 1980 · 135 citations

Medicine, Endocrinology, Pharmacology +7

Growth Regulation of Prostatic Stromal Cells by Prostate-Specific Antigen

Debra M. Sutkowski, Robin L. Goode, Jack Baniel et al. · JNCI Journal of the National Cancer Institute · 1999 · 78 citations · Full text

Life Sciences, Cell Biology, Endocrinology +14

The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.

Blake Lee Neubauer, Ann M. McNulty, Márcio F. Chedid et al. · PubMed · 2003 · 44 citations

Medicine, Oncology, Pharmacology +14